Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of MCC mRNA | increases expression | 19933214
|
D019256 |
Cadmium Chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MCC mRNA | affects cotreatment|decreases expression | 12634122
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of MCC mRNA | affects expression | 17484886
|
C023600 |
chromium oxide |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MCC mRNA | affects cotreatment|decreases expression | 12634122
|
C017133 |
chromous chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MCC mRNA | affects cotreatment|decreases expression | 12634122
|
C008261 |
lead acetate |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MCC mRNA | affects cotreatment|decreases expression | 12634122
|
D015741 |
Metribolone |
Metribolone results in increased expression of MCC mRNA | increases expression | 17010196
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MCC mRNA | affects cotreatment|decreases expression | 12634122
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of MCC mRNA | increases expression | 17879257
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MCC mRNA | increases expression | 19465110 19933214
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.13 | 15322242 14514962 11752688 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.66 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
marker/mechanism |
|
| 8071957 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.02 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.22 | 17306315 16712894 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 8071957 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.25 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.69 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
4.04 | 10355542 15673190 16097048 15721981 16192424 16011737 3786805 15700767 16050911 16227642 18705752 16124888 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
3.15 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.15 | 16507464 17306315 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.43 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
3.12 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.18 | 16354765 12621046 15668235 15340226 8697196 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
2.98 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 10048152 15322242 20055451 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
3.89 | 16177239 6884620 19085960 3786805 7440962 7179309 10915739 19336974 4309450 15998439 2869522 10092053 21278145 3732212 17522070 11566570 9327722 16227642 15968718 15027814 7120509 6623471 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.89 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.58 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 16714409 18230668 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
3.37 | 12795759 16239168 12631006 17595544 15959796 19224547 61145 16045604 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
5.62 | 19769572 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
9.47 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.47 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.96 | 16452187 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.43 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.83 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.15 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.33 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 16354765 8697196 18606429 16959395 15340226 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.82 | 16899240 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.35 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.12 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.95 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
6.79 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.79 | 20008137 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.91 | 16943688 21278145 16221502 11408273 17334410 16239168 17174718 11903743 17157831 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
2.34 | 17640975 17805973 17900296 15818738 18420326 15931870 18166357 18339082 18317297 14620537 18187930 17708605 12667390 17557913 17565644 18210741 18395095 18412020 12609069 15362042 15893842 14748882 17525996 18277467 17766677 12546737 18429990 18251166 17976157 16638106 18418968 17761835 17631135 15996030 16011737 12741479 16192424 17714472 14716833 18006644 18263696 14512876 12632512 12389079 15959796 12898905 18156304 15925388 18705752 15123356 11481614 12649538 15057751 16248980 15650968 17922224 16027843 17698563 14724832 18472094 12445418 16136751 16015684 15338365 15052691 12632514 16116963 15370692 12958196 18472332 13678700 15730626 17944888 17481882 20821823 17869086 16033810 18376398 15876570 12666154 18481824 18054572 16097048 18395914 12445421 15673190 17721639 17823541 12586293 14716496 18279442 10355542 18205269 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.34 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.12 | 15720792 16964402 17285989 16246199 15830285 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.42 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.88 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
7.81 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.81 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.81 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
6.16 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.16 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.30 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.35 | 16712894 15276417 17306315 19931552 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 11884234 19555203 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.05 | 19082730 16487513 |
MESH:D008607 |
Mental Retardation |
marker/mechanism |
|
| 8071957 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.58 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.92 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.45 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.27 | 12854658 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.49 | 17306315 15276417 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.48 | 11896295 11222880 11118676 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.27 | 16039940 |
MESH:D012004 |
Rectal Neoplasms |
marker/mechanism |
|
| 8071957 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.88 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.88 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.95 | 12854658 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.57 | 16712894 17306315 16452187 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.96 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.71 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |